GlassScriptPhysician profile
Michael James Goebel
NPI 1114967189
$3,356.88
in general payments reported to CMS, 2019-2025
28 companies · $433 in 2025
The $433 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $159 · 2021: $1,395 · 2022: $321 · 2023: $86.83 · 2024: $386 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $1,959.09 | 2021-2025 | Prodisc C Vivo |
| Medtronic, INC. | $217.48 | 2024-2025 | Intellis Adaptivestim, Vectris Surescan, Mastergraft Matrix Ext |
| Arteriocyte Medical Systems, INC. | $159.50 | 2019-2023 | Magellan |
| Pacira Therapeutics, INC. | $138.29 | 2019-2020 | |
| Globus Medical, INC. | $111.01 | 2019-2025 | Senza |
| Kyocera Medical Technologies, INC. | $107.50 | 2020 | |
| Orthofix Medical, INC. | $70.26 | 2019-2025 | Cervical-Stim |
| Aesculap Implant Systems, LLC | $69.89 | 2019 | |
| Stryker Corporation | $66.15 | 2025 | Clottriever Bold Catheter |
| Cerapedics INC. | $52.48 | 2019-2025 | I-Factor Peptide Enhanced Bone Graft |
| Radius Health, INC. | $42.43 | 2023 | Tymlos |
| Vertex Pharmaceuticals Incorporated | $38.03 | 2024-2025 | |
| Amgen INC. | $37.98 | 2019-2024 | Evenity, Prolia |
| Treace Medical Concepts, INC. | $35.80 | 2025 | |
| Endo Pharmaceuticals INC. | $26.93 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intrinsic Therapeutics | $25.28 | 2025 | Barricaid Acd (Annular Closure Device) |
| Pacira Pharmaceuticals Incorporated | $24.18 | 2023 | Exparel, Zilretta, Iovera |
| Vericel Corporation | $21.39 | 2025 | |
| Abbott Laboratories | $20.33 | 2024 | Penta |
| Smith+Nephew, INC. | $17.22 | 2019 | |
| Acell, INC. | $17.01 | 2019 | |
| Inari Medical, INC. | $15.96 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Spineology INC. | $14.66 | 2020 | |
| Daiichi Sankyo INC. | $14.07 | 2020 | |
| Djo, LLC | $14.05 | 2019 | |
| Nevro Corp. | $14.03 | 2019 | |
| Hospira, INC. | $13.44 | 2022 | |
| Mallinckrodt Enterprises LLC | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Goebel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.